Literature DB >> 10192272

Developmental effects of phenytoin may differ depending on sex of offspring.

M A McCartney1, P L Scinto, S S Wang, S Altan.   

Abstract

Phenytoin (sodium salt), a developmental neurotoxicant, was administered orally by gavage (50-150 mg/kg) to pregnant rats on days 7-18 of gestation. Various developmental and behavioral indices were evaluated. Results indicated that phenytoin produced decreases in maternal and pup body weight gains, pup hindbrain, and F1 adult forebrain, whole brain, and cerebellar weights. Behavioral/developmental effects included performance deficits in a modified Morris water maze assay, in air righting and auditory startle responses, and increases in locomotor activity, accelerated eye opening, incisor eruption, negative geotaxis, and olfactory orientation. Female offspring appeared to be more severely affected when measuring incisor eruption, negative geotaxis, air righting, reactivity, and locomotor and maze activity. Males appeared to be more affected when measuring eye opening, olfactory orientation, and decreases in startle response. This study suggests that prenatal phenytoin exposure may result in developmental changes and behavioral deficits that may differ depending on the sex of the offspring.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10192272     DOI: 10.1016/s0892-0362(98)00047-6

Source DB:  PubMed          Journal:  Neurotoxicol Teratol        ISSN: 0892-0362            Impact factor:   3.763


  2 in total

1.  Exposures to environmental toxicants and attention deficit hyperactivity disorder in U.S. children.

Authors:  Joe M Braun; Robert S Kahn; Tanya Froehlich; Peggy Auinger; Bruce P Lanphear
Journal:  Environ Health Perspect       Date:  2006-12       Impact factor: 9.031

2.  Reference compounds for alternative test methods to indicate developmental neurotoxicity (DNT) potential of chemicals: example lists and criteria for their selection and use.

Authors:  Michael Aschner; Sandra Ceccatelli; Mardas Daneshian; Ellen Fritsche; Nina Hasiwa; Thomas Hartung; Helena T Hogberg; Marcel Leist; Abby Li; William R Mundi; Stephanie Padilla; Aldert H Piersma; Anna Bal-Price; Andrea Seiler; Remco H Westerink; Bastian Zimmer; Pamela J Lein
Journal:  ALTEX       Date:  2016-07-25       Impact factor: 6.043

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.